The NRBDO has taken a position in favour of paid plasma collection:
Position Paper on Paid Plasma
Letter to Senators re: Bill S-252 - June 2018
Response from Senator Wallin - June 2018
Submission to Expert Panel on Immune Globulins Product Supply and Related Impacts in Canada - October 2017
Letter to BC Minister of Health - September 2017
Statement read at the Canadian Blood Services Open Board Meeting - June 2016
Letter to Federal Minister of Health in support of Paid Plasma Collection - February 2016
Letter to Prov/Terr Blood Liaison Committee regarding Ontario Bill 21 - December 2014
Ontario Bill 21 Hearings: NRBDO Testimony December 2014
Position Paper on Paid Plasma
Letter to Senators re: Bill S-252 - June 2018
Response from Senator Wallin - June 2018
Submission to Expert Panel on Immune Globulins Product Supply and Related Impacts in Canada - October 2017
Letter to BC Minister of Health - September 2017
Statement read at the Canadian Blood Services Open Board Meeting - June 2016
Letter to Federal Minister of Health in support of Paid Plasma Collection - February 2016
Letter to Prov/Terr Blood Liaison Committee regarding Ontario Bill 21 - December 2014
Ontario Bill 21 Hearings: NRBDO Testimony December 2014
The NRBDO requests a review of the secondary restriction on the use of Solvent Detergent Plasma (SDP):
Letter to National Advisory Committee on Blood and Blood Products - October 2018
Letter to the Prov./Terr. Blood Liaison Committee - February 2017
Letter to National Advisory Committee on Blood and Blood Products - October 2018
Letter to the Prov./Terr. Blood Liaison Committee - February 2017
Other Advocacy Position & Letters:
Position Statement on Blood Product Distribution
Position Statement on MSM Deferral Policies (updated 2018)
Position Statement on a National Pharmacare Program
Letter to P/T Deputy Ministers of Health re: new blood product review process - June 2018
Letter to Innovative Medicines Canada re: travel reimbursement for medical professionals - June 2018
Questionnaire for Ontario Election Candidates - 2018
Summary Report
Ontario Pre-budget Submission, advocating for Comprehensive Care - February 2018
Letter to CADTH requesting Path for Patient Input in Blood Product Reviews - January 2018
Letter to CADTH requesting Path for Patient Input in Blood Product Reviews - CBS cover - January 2018
Letter to CBS regarding product tender process and outcomes, from CSACI and AMMI Canada,
which the NRBDO also signed on to - December 2017
Letter to the Federal Minister of Health in support of the Orphan Drug Framework - January 2016
Letter in support of a move from a 5-yr to 1-yr MSM deferral by CBS - November 2015
Press Release Announcing 1-yr deferral by the Minister of Health - June 2016
Letter in support of expanded newborn screening in Alberta - October 2015
Position Statement on Blood Product Distribution
Position Statement on MSM Deferral Policies (updated 2018)
Position Statement on a National Pharmacare Program
Letter to P/T Deputy Ministers of Health re: new blood product review process - June 2018
Letter to Innovative Medicines Canada re: travel reimbursement for medical professionals - June 2018
Questionnaire for Ontario Election Candidates - 2018
Summary Report
Ontario Pre-budget Submission, advocating for Comprehensive Care - February 2018
Letter to CADTH requesting Path for Patient Input in Blood Product Reviews - January 2018
Letter to CADTH requesting Path for Patient Input in Blood Product Reviews - CBS cover - January 2018
Letter to CBS regarding product tender process and outcomes, from CSACI and AMMI Canada,
which the NRBDO also signed on to - December 2017
Letter to the Federal Minister of Health in support of the Orphan Drug Framework - January 2016
Letter in support of a move from a 5-yr to 1-yr MSM deferral by CBS - November 2015
Press Release Announcing 1-yr deferral by the Minister of Health - June 2016
Letter in support of expanded newborn screening in Alberta - October 2015